Document is current
Any future updates will be listed below
-
Authors
Spanogiannopoulos, Peter
Kyaw, Than S. https://orcid.org/0000-0002-7933-8615
Guthrie, Ben G. H. https://orcid.org/0000-0001-9694-7263
Bradley, Patrick H. https://orcid.org/0000-0002-9231-8344
Lee, Joyce V.
Melamed, Jonathan https://orcid.org/0000-0002-5981-7766
Malig, Ysabella Noelle Amora
Lam, Kathy N.
Gempis, Daryll
Sandy, Moriah
Kidder, Wesley
Van Blarigan, Erin L.
Atreya, Chloe E.
Venook, Alan
Gerona, Roy R.
Goga, Andrei https://orcid.org/0000-0001-9127-0986
Pollard, Katherine S. https://orcid.org/0000-0002-9870-6196
Turnbaugh, Peter J. https://orcid.org/0000-0002-0888-2875
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R21CA227232)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01HL122593)
- License Information
-
More Information
Article History
Received: 29 May 2022
Accepted: 3 August 2022
First Online: 22 September 2022
Competing interests
: P.J.T. is on the scientific advisory boards of Pendulum, Seed and SNIPRbiome; there is no direct overlap between the current study and these consulting duties. K.S.P. is on the scientific advisory board of Phylagen; there is no direct overlap between the current study and these consulting duties. C.E.A serves on the scientific advisory board of Pionyr Immunotherapeutics and has received research funding (institution) from Bristol Meyer Squibb, Guardant Health, Kura Oncology, Merck and Novartis; there is no direct overlap with the current study. All other authors declare no competing interests.
